The United States Bovine Disease ELISA Kit Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031.
United States Bovine Disease ELISA Kit Market By Application
- Mycoplasmal Pneumonia
- Johne’s Disease
- Salmonellosis
- Brucellosis
- Others
The United States market for bovine disease ELISA kits is segmented by application into several key areas. Mycoplasmal pneumonia represents a significant portion of the market, as it remains one of the most prevalent respiratory diseases affecting cattle. ELISA kits designed for detecting antibodies against Mycoplasma bovis are crucial for early diagnosis and management of this disease. Johne’s Disease, another key application segment, drives demand for ELISA kits that detect Mycobacterium avium subsp. paratuberculosis (MAP) antibodies in cattle, aiding in the control of this chronic enteritis.
Furthermore, the market includes ELISA kits for detecting Salmonellosis, a bacterial infection that poses significant economic losses in cattle production. These kits are essential for rapid identification and containment of Salmonella outbreaks. Brucellosis, although less prevalent due to successful eradication efforts, still requires robust diagnostic tools. ELISA kits targeting Brucella spp. antibodies play a crucial role in surveillance and control programs. Lastly, other applications such as detecting antibodies against Bovine viral diarrhea virus (BVDV) and Infectious Bovine Rhinotracheitis (IBR) contribute to the overall diversity and growth of the bovine disease ELISA kit market in the United States.